1. Home
  2. SRPT vs CUBE Comparison

SRPT vs CUBE Comparison

Compare SRPT & CUBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • CUBE
  • Stock Information
  • Founded
  • SRPT 1980
  • CUBE 2004
  • Country
  • SRPT United States
  • CUBE United States
  • Employees
  • SRPT N/A
  • CUBE N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • CUBE Real Estate Investment Trusts
  • Sector
  • SRPT Health Care
  • CUBE Real Estate
  • Exchange
  • SRPT Nasdaq
  • CUBE Nasdaq
  • Market Cap
  • SRPT 12.2B
  • CUBE 10.5B
  • IPO Year
  • SRPT 1997
  • CUBE 2004
  • Fundamental
  • Price
  • SRPT $120.39
  • CUBE $43.86
  • Analyst Decision
  • SRPT Buy
  • CUBE Hold
  • Analyst Count
  • SRPT 21
  • CUBE 11
  • Target Price
  • SRPT $179.38
  • CUBE $51.36
  • AVG Volume (30 Days)
  • SRPT 1.0M
  • CUBE 1.2M
  • Earning Date
  • SRPT 11-06-2024
  • CUBE 10-31-2024
  • Dividend Yield
  • SRPT N/A
  • CUBE 4.45%
  • EPS Growth
  • SRPT N/A
  • CUBE 5.93
  • EPS
  • SRPT 1.22
  • CUBE 1.78
  • Revenue
  • SRPT $1,640,348,000.00
  • CUBE $1,066,921,000.00
  • Revenue This Year
  • SRPT $50.40
  • CUBE N/A
  • Revenue Next Year
  • SRPT $71.44
  • CUBE $3.04
  • P/E Ratio
  • SRPT $103.94
  • CUBE $25.76
  • Revenue Growth
  • SRPT 48.45
  • CUBE 1.56
  • 52 Week Low
  • SRPT $89.92
  • CUBE $39.80
  • 52 Week High
  • SRPT $173.25
  • CUBE $55.14
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 50.01
  • CUBE 29.15
  • Support Level
  • SRPT $122.12
  • CUBE $46.09
  • Resistance Level
  • SRPT $128.73
  • CUBE $47.76
  • Average True Range (ATR)
  • SRPT 3.87
  • CUBE 0.73
  • MACD
  • SRPT -0.15
  • CUBE -0.26
  • Stochastic Oscillator
  • SRPT 11.14
  • CUBE 6.06

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.

About CUBE CubeSmart

CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Most of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. The company derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.

Share on Social Networks: